Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Seagate Technology Holdings PLC — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Seagate Technology Holdings PLC trades at $878.71 (market cap $205.97B). The key difference: Seagate Technology Holdings PLC pays a 0.33% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | STX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $1.09K |
52-Week Low | $23.09 | $146.59 |
Market Cap | — | $205.97B |
Enterprise Value | — | $209.00B |
Dividend Yield | — | 0.33% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Seagate Technology (STX) trades at $910.34, up 2.28% with strong momentum driven by AI infrastructure demand. The stock shows impressive fundamental improvement with revenue growth from $6.6B to $9.1B and net income surging to $1.47B in 2025. Technical indicators are mixed with bullish moving averages but neutral oscillators, while analyst sentiment remains positive with a $981.43 consensus target representing 7.8% upside potential.
STX presents compelling growth prospects as AI-driven storage demand accelerates, supported by three consecutive earnings beats and expanding margins. Key risks include high valuation multiples (P/E 86.37), significant debt levels, and competitive pressures in the storage market. The company's positioning in AI infrastructure and strong institutional support suggest continued upside potential despite elevated valuation concerns.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →